ACSL4 and chronic obstructive pulmonary disease: Wang et al. [66] reported that both Lv-shACSL4-treated COPD mouse models and siACSL4-transfected cells effectively suppressed ACSL4 expression, decreased lipid peroxidation, and downregulated ferroptosis markers in vivo and in vitro.